• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    P

    Prisma Health

    EST. 1912
    1,468论文总数
    2.7万引用总数

    论文量&引用量时间轴

    机构学者

    论文(1468)

    年份
    起
    –
    止
    排序
    1Developing a Core Outcome Set for the NeuroPoint Alliance Quality Outcomes Database Pediatric Tumor Surgery Registry: a Modified Delphi Study.
    David S. Hersh,Anthony L. Asher, Mohamad Bydon, Maliya Delawan,Ian F. Pollack, Jason S. Hauptman, Eric M. Thompson,Michael C. Dewan,S. Hassan. A. Akbari, Karl Balsara, Randaline R. Barnett, Marian M. Bercu,

    Prospective, multi-institutional surgical data collection in pediatric neuro-oncology remains limited despite substantial variation in operative and perioperative management across institutions. To address this, we are developing the NeuroPoint Alliance (NPA) Quality Outcomes Database (QOD) Pediatric Tumor Surgery Registry. Here, we used a modified Delphi process to define a core outcome set for the registry. A modified Delphi study was conducted among pediatric neurosurgeons serving as site principal investigators for the proposed registry. Candidate data elements were rated on a 9-point Likert scale. Consensus for inclusion was predefined as ≥70

    2026Journal of Neuro-Oncology(2026)引用:28
    引用
    AI阅读
    加入学术空间
    2Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on COVID-19 Preventative Behaviors among Persons Who Inject Drugs with Hepatitis C: the HERO Study.
    Snehal S Lopes,Irene Pericot-Valverde,Paula J Lum,Lynn E Taylor,Shruti H Mehta, Judith I Tsui,Judith Feinberg, Arthur Y Kim, Brianna L Norton,Kimberly Page,Cristina Murray-Krezan, Jessica Anderson,

    BACKGROUND:Personal protective measures help prevent infection and disease transmission during health crises such as Coronavirus disease 2019 (COVID-19). Populations facing barriers to adhering to these measures are more vulnerable to the health crisis. This study investigated the association of social drivers of health (SDoH), self-efficacy, and adverse substance use behavior changes with ability to practice COVID-19 personal protective behaviors among persons who inject drugs (PWID) with hepatitis C virus (HCV) infection history. METHODS:This study used the Hepatitis C Real Options (HERO) study's COVID-19 survey data (n = 157). The association of inability to practice COVID-19 personal protective behaviors (hand washing, social distancing, etc.) with (a) SDoH difficulties (employment, housing, etc.); (b) adverse substance use behavior change (overdose, injecting behavior, etc.); and (c) self-efficacy was tested using logistic regression. RESULTS:Inability to practice any personal protective behaviors was more likely among those experiencing any vs. no SDoH difficulties [adjusted odds ratio (aOR) (95% confidence interval (CI))] = 4.57 (1.57, 16.40); p = 0.003] but less likely for those with higher overall self-efficacy [aOR (95% CI) = 0.55 (0.32, 0.93); p = 0.025] and self-efficacy for setting goals [aOR (95% CI) = 0.63 (0.40, 0.96); p = 0.031]. The association between adverse substance use behavior changes and the outcome was not significant. CONCLUSIONS:Greater SDoH difficulties and lower self-efficacy were associated with greater inability to practice COVID-19 personal protective behaviors. Interventions to meet SDoH-related challenges and increase self-efficacy could help encourage practice of personal protective behaviors and economically reduce disease burden during health crises.

    2026International journal of environmental research and public health(2026)引用:1
    引用
    AI阅读
    加入学术空间
    3Obesity Management: Surgical Interventions.
    Mark Shaffer, Matthew Nodelman, A Miles Scott, Morgan A Rhodes

    Metabolic and bariatric surgery (MBS) is surgery on the gastrointestinal tract aimed at weight loss and resolution of metabolic disease. These surgeries can result in remission of diabetes, hypertension, and sleep apnea in many patients, and can prolong life expectancy by 5 to 9 years. Because of the proven benefits, the American Society for Metabolic and Bariatric Surgery recommends surgery for all patients with a body mass index of 35 kg/m2 or higher, except for patients with diabetes whose threshold is 30 kg/m2 regardless of prior nonsurgical weight loss efforts. For children 13 years and older, MBS is recommended and has not been shown to negatively affect height or develop- ment. The MBS procedures have a very low risk of surgical complications but require careful preoperative counseling due to the major long-term effect expected on lifestyle. Family physicians are well suited to discuss MBS as an option for appropriate patients, refer to a qualified center, and monitor patients postoperatively. Attention must be given to effects on diet, fertility, and mental health, and adjustments must be made for long-term medications. These surgeries should not be viewed as a last resort for only patients with severe obesity but as an effective intervention to consider early in the treatment of obesity, especially when complicated by metabolic conditions.

    2026FP essentials(2026)
    引用
    AI阅读
    加入学术空间
    4Developing Buoyant-Analyte-Magnetic (BAM) Assays for Ultrasensitive Yet Rapid Point-of-Care Detection
    Chuanlei Wang, Emory Satterfield, Nicholas Erwin, Jose Correa, Wesley Wampler,Delphine Dean, Phillip Moschella, Jeffrey Anker

    Rapidly detecting infectious diseases such as Covid-19 is essential to control outbreaks and treat patients early. However, no available screening method combines low cost, portability, speed (<20 min, ideally <5 min), and ultrasensitivity (e.g., <1 virus/μL): lateral flow assays are fast, portable, and inexpensive but insensitive, whereas ultrasensitive assays require centralized labs with long turnaround times. We recently developed an ultrasensitive immunoassay that captures, separates, and counts saliva biomarker molecules using buoyant microbubbles and magnetic microspheres, but the original assay took 55 minutes and was not readily deployable. Here, we redesigned the assay protocol and reader for emergency medicine and mobile care by streamlining the workflow, collecting saliva with larger swabs, filtering it through a 10 μm cap, and using larger microbubbles to accelerate flotation. A paramedic successfully ran the assay on the back of a parked medical van in 3.5 minutes (spit-to-results) while achieving a 1.3 fg/mL analytical detection limit for SARS-CoV-2 nucleocapsid protein (~0.04 virus1/μL). The assay remained positive across 9 orders of magnitude. We describe the challenges and opportunities ahead for point-of-care deployment. ### Competing Interest Statement Dr. Anker is a Scientific Advisor for Akadeum Life Sciences, the company that sells the buoyant microbubbles used in the BAM assay, which owns the rights to a patent describing buoyant and magnetic analyte labeling and detection (US Patent 10,724,930). All other authors declare no competing interests. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Approval was from the Institutional Review Board (IRB) of Clemson University (IRB2021-0703) and the Institutional Review Board of Prisma Health (Pro00100731) I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All data generated or analyzed during this study are included in this published article and its supplementary information files or are available from the corresponding author upon reasonable request. COVID Testing Research Seed Grant Program from Clemson University Agilent Technologies Inc., Applications and Core Technology – University Relations (ACT-UR), 4599 Clemson University Creative Inquiry and Summer UR programs, 1852 Prisma Health, https://ror.org/03n7vd314

    2026
    引用
    AI阅读
    加入学术空间
    5The Impact of Group Prenatal Care on Breastfeeding: A Planned Secondary Analysis of the CRADLE Randomized Controlled Trial
    Alexa I. K. Campbell, Meghan DuBose,Jessica Britt,Moonseong Heo,Lu Zhang,Liwei Chen,Lauren Keenan‐Devlin,Amy H. Crockett

    Abstract Background Despite providing both maternal and neonatal benefits, breastfeeding rates remain lower than goal targets. Prior observational studies suggest group prenatal care (GPNC) increases breastfeeding initiation compared to individual prenatal care (IPNC), but few randomized controlled trials (RCTs) have examined how GPNC impacts breastfeeding knowledge and self‐efficacy. We aimed to determine if participating in GPNC impacts breastfeeding knowledge, breastfeeding self‐efficacy, and breastfeeding prevalence postpartum. Materials and methods This is a planned secondary analysis of the Centering and Racial Disparities (CRADLE) RCT comparing the impact of GPNC versus IPNC on preterm birth. The CRADLE trial enrolled 2350 participants and randomized them to GPNC or IPNC. Eligibility requirements included age of 14–45 years, singleton pregnancy, entering prenatal care before 21 weeks’ gestation, and low‐risk pregnancy by institutional standards. Questionnaires assessed breastfeeding knowledge (adapted from the Infant Feeding Practices II Survey) and self‐efficacy (adapted from Wells’ 20‐item Prenatal Breast‐feeding Self‐Efficacy Scale). A per‐compliance approach was used, including participants who attended at least five sessions in their assigned group. The primary outcome was breastfeeding at hospital discharge. Secondary outcomes were breastfeeding knowledge, breastfeeding self‐efficacy, and breastfeeding prevalence at the postpartum visit. Chi‐square, Students’ t‐test, and multivariable logistic regression were applied. Additionally, a sensitivity analysis was conducted among nulliparous participants. Results Of the 2350 participants in the CRADLE study, 1561 were included in this secondary analysis. Participants self‐identified as Black (38.3%), Hispanic (24.2%), White (36.2%), or another race and ethnicity (1.3%), and the majority were multiparous. GPNC participants reported higher rates of breastfeeding at hospital discharge compared to IPNC (72.8% IPNC vs. 78.2% GPNC; adjusted odds ratio [aOR], 1.32; 95% confidence interval [CI], 1.02–1.72). GPNC participants also had greater breastfeeding knowledge, scoring higher on the composite knowledge questionnaire (score 18.5, standard deviation [SD] 4.3) compared to IPNC participants (score 17.5, SD 4.4; p < 0.001). No differences were observed in self‐efficacy scores or postpartum breastfeeding rates between GPNC and IPNC participants. These findings were generally consistent for nulliparous participants; however, breastfeeding rate at hospital discharge did not differ between arms. Conclusion GPNC increased breastfeeding knowledge and breastfeeding at hospital discharge but not breastfeeding at the postpartum visit. These findings suggest that education alone may be insufficient to create long‐lasting changes in breastfeeding behavior.

    2026Pregnancy(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1468 篇论文

    合作机构(100)

    南卡罗来纳大学合作论文 154
    克莱姆森大学合作论文 151
    华盛顿大学合作论文 44
    杜克大学合作论文 43
    北卡罗来纳大学系统合作论文 42
    温纳贝戈医学中心合作论文 41
    南卡罗来纳医科大学合作论文 39
    阿拉巴马大学伯明翰分校合作论文 29
    克利夫兰诊所合作论文 27
    埃默里大学合作论文 27

    机构统计